Document is current
Any future updates will be listed below
-
Authors
Vervloet, Marcia http://orcid.org/0000-0002-0325-9814
van Dijk, Liset
Weesie, Yvette M.
Kocks, Janwillem W. H. http://orcid.org/0000-0002-2760-0693
Dima, Alexandra L. http://orcid.org/0000-0002-3106-2242
Korevaar, Joke C.
-
Funding
Funding for this research was provided by:
This study was funded by AstraZeneca
- License Information
-
More Information
Article History
Received: 11 October 2021
Accepted: 6 October 2022
First Online: 21 October 2022
Competing interests
: M.V. and L.v.D. received funding for research unrelated to this study from Pfizer, AbbVie, Teva. J.W.H.K. reports grants, personal fees, and non-financial support from AstraZeneca, grants, personal fees, and non-financial support from Boehringer Ingelheim, grants and personal fees from Chiesi Pharmaceuticals, grants, personal fees, and non-financial support from GSK, grants from Mundi Pharma, grants and personal fees from TEVA, personal fees from MSD, personal fees from COVIS Pharma, outside the submitted work; all fees go to his institute; he holds 72.5% of shares in the General Practitioners Research Institute. J.C.K. received funding unrelated to this study from Bayer B.V. Y.M.W. and A.L.D. have no conflicts of interest to declare.
